Growth Metrics

Eli Lilly (LLY) Minority Interest (2016 - 2025)

Eli Lilly's Minority Interest history spans 17 years, with the latest figure at $57.5 million for Q3 2025.

  • For Q3 2025, Minority Interest fell 28.75% year-over-year to $57.5 million; the TTM value through Sep 2025 reached $57.5 million, down 28.75%, while the annual FY2024 figure was $79.5 million, 13.4% down from the prior year.
  • Minority Interest reached $57.5 million in Q3 2025 per LLY's latest filing, down from $76.2 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $219.1 million in Q2 2021 to a low of $57.5 million in Q3 2025.
  • Average Minority Interest over 5 years is $113.8 million, with a median of $91.8 million recorded in 2023.
  • Peak YoY movement for Minority Interest: surged 69.43% in 2021, then crashed 51.4% in 2022.
  • A 5-year view of Minority Interest shows it stood at $175.6 million in 2021, then decreased by 28.47% to $125.6 million in 2022, then dropped by 26.91% to $91.8 million in 2023, then fell by 13.4% to $79.5 million in 2024, then decreased by 27.67% to $57.5 million in 2025.
  • Per Business Quant, the three most recent readings for LLY's Minority Interest are $57.5 million (Q3 2025), $76.2 million (Q2 2025), and $82.0 million (Q1 2025).